Morphine Binds Creatine Kinase B and Inhibits Its Activity

Area of Science:

• Biochemistry
• Neuroscience
• Pharmacology

Background:

• Morphine, an analgesic, causes irreversible protein binding.
• Chronic morphine use alters brain energy metabolism enzyme expression, leading to behavioral abnormalities.
• Creatine kinase B (CK-B) is a crucial enzyme in brain energy metabolism and binds dopamine.

Purpose of the Study:

• To investigate the interaction between morphine and creatine kinase B (CK-B).
• To determine if CK-B is a direct binding target for morphine.
• To assess the functional consequences of morphine binding on CK-B activity.

Main Methods:

• Biochemical assays using recombinant mouse CK-B.
• In vitro binding studies with morphine.
• Enzyme activity assays.
• In vivo administration of morphine to mice followed by brain extract analysis.

Main Results:

• Recombinant mouse CK-B exhibits a micromolar affinity for morphine, binding it in vitro.
• The CK-B-morphine complex is highly stable, resisting detergents, reducing agents, heat, and SDS-PAGE.
• Specific CK-B peptides (CK-B1-75 and CK-B184-258) were identified as morphine-binding sites.
• Morphine significantly reduces CK-B enzymatic activity in vitro.
• In vivo morphine administration decreases CK-B activity in mouse brain extracts.

Conclusions:

• Morphine directly and strongly binds to creatine kinase B (CK-B).
• This binding event inhibits CK-B enzymatic activity both in vitro and in vivo.
• CK-B is identified as a novel direct target of morphine, offering insights into morphine's mechanism of action and associated neurological effects.